3649 Stock Overview
Offers medical systems, office systems, and medical equipment solutions in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for 3649 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
FINDEX Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥862.00 |
| 52 Week High | JP¥1,289.00 |
| 52 Week Low | JP¥770.00 |
| Beta | 0.71 |
| 1 Month Change | 5.90% |
| 3 Month Change | 1.06% |
| 1 Year Change | -6.30% |
| 3 Year Change | -10.40% |
| 5 Year Change | -32.07% |
| Change since IPO | 910.16% |
Recent News & Updates
Recent updates
FINDEX Inc.'s (TSE:3649) Popularity With Investors Is Under Threat From Overpricing
Sep 05
FINDEX (TSE:3649) Will Pay A Dividend Of ¥7.00
Jun 07FINDEX (TSE:3649) Is Due To Pay A Dividend Of ¥7.00
Apr 25FINDEX (TSE:3649) Is Due To Pay A Dividend Of ¥7.00
Apr 11After Leaping 29% FINDEX Inc. (TSE:3649) Shares Are Not Flying Under The Radar
Mar 10Shareholder Returns
| 3649 | JP Healthcare Services | JP Market | |
|---|---|---|---|
| 7D | 0.7% | -0.7% | -2.5% |
| 1Y | -6.3% | -31.8% | 7.2% |
Return vs Industry: 3649 exceeded the JP Healthcare Services industry which returned -31.8% over the past year.
Return vs Market: 3649 underperformed the JP Market which returned 7.2% over the past year.
Price Volatility
| 3649 volatility | |
|---|---|
| 3649 Average Weekly Movement | 3.2% |
| Healthcare Services Industry Average Movement | 4.9% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 3649 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 3649's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 290 | Teruo Aibara | findex.co.jp |
FINDEX Inc. offers medical systems, office systems, and medical equipment solutions in Japan. It operates through three segments: Medical Business, Public Business, and Healthtech Business. The company provides Claio image filing system, C-Scan paper and digital document management system, DocuMaker document creation system, PDI+MoveBy referral information management system, C-Note medical record recording system, MapleNote perinatal system, REMORA electronic medical record, ID-Cam/Claio-Cam digital camera solution, UniversalSearcher medical big data search system, FAXde regional collaboration FAX referral management system, LIS endoscope system endoscope department system, LIS ultrasound system ultrasound department system, ProRad RIS radiology department system, ProRad RS radiology reporting system, ProRad QA integrated imaging system, C-Peri/C-Peri ME integrated field viewer, C-Nys / C-Nys ME Nystagmus analysis support system, Remotalk-Cloud remote medical information sharing app, Cloud backup service security service, Dodo - a task management app for parents and children, PiCls Medical Avenue for patient information app, PiCls On-shin online medical support system, PiCls AAdE-report electronic tracing report service, PiCls reservation assistant first visit online reservation service, PiCls referral medical information transfer system, Weberi internet browsing virtualization service, Bricks cloud-based general-purpose EDC/medical questionnaire system, and Valloon Closed cloud-based data storage; and DocuMaker office, a document management and electronic approval system for municipality and medical institutions; and DocuMaker shelf electronic book keeping solution.
FINDEX Inc. Fundamentals Summary
| 3649 fundamental statistics | |
|---|---|
| Market cap | JP¥22.13b |
| Earnings (TTM) | JP¥1.32b |
| Revenue (TTM) | JP¥6.03b |
16.7x
P/E Ratio3.7x
P/S RatioIs 3649 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3649 income statement (TTM) | |
|---|---|
| Revenue | JP¥6.03b |
| Cost of Revenue | JP¥2.23b |
| Gross Profit | JP¥3.80b |
| Other Expenses | JP¥2.48b |
| Earnings | JP¥1.32b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 13, 2025
| Earnings per share (EPS) | 51.56 |
| Gross Margin | 63.02% |
| Net Profit Margin | 21.96% |
| Debt/Equity Ratio | 0% |
How did 3649 perform over the long term?
See historical performance and comparisonDividends
1.7%
Current Dividend Yield31%
Payout RatioDoes 3649 pay a reliable dividends?
See 3649 dividend history and benchmarks| FINDEX dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Mar 28 2025 |
| Days until Ex dividend | 17 days |
| Days until Dividend pay date | 74 days |
Does 3649 pay a reliable dividends?
See 3649 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/12 10:41 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
FINDEX Inc. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Masatoshi Nagata | Ichiyoshi Research Institute Inc. |
| Hidekatsu Watanabe | Mizuho Securities Co., Ltd. |
| Kyoichiro Shigemura | Nomura Securities Co. Ltd. |